글로벌 헤르페스 시장 – 2031년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Healthcare Global Herpes Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

글로벌 헤르페스 시장 – 2031년까지의 산업 동향 및 예측

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60
지금 구매 지금 구매

글로벌 헤르페스 시장, 바이러스 유형(단순포진 및 대상포진), 제품(아시클로비르, 도코사놀, 발라시클로비르, 파미시클로비르 및 기타), 약물 유형(처방약 및 일반 의약품), 연령(성인 및 소아), 투여 경로(국소, 경구 및 비경구), 유통 채널(병원 약국, 소매 약국, 약국, 온라인 약국 및 기타), 최종 사용자(특수 진료소 및 기타) - 산업 동향 및 2031년까지의 예측.

헤르페스 시장

헤르페스 시장 분석 및 규모

헤르페스 시장은 헤르페스 심플렉스 바이러스(HSV) 감염을 표적으로 하는 처방약과 일반 의약품을 포함합니다. 발라시클로비르(Valtrex)와 같은 처방약은 발병을 관리하고 바이러스 활동을 억제하는 데 널리 사용됩니다. 도코사놀(Abreva)이 함유된 국소 크림과 같은 일반 의약품은 증상 완화를 제공합니다. 이 시장은 HSV 감염의 급성 치료와 장기 관리를 모두 다루며 다양한 소비자의 요구와 선호도에 부응합니다.

Data Bridge Market Research는 2023년에 12억 4천만 달러였던 글로벌 헤르페스 시장이 2031년까지 20억 6천만 달러에 도달할 것으로 분석했으며, 2024년부터 2031년까지의 예측 기간 동안 연평균 성장률은 6.6%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

헤르페스 시장 범위 및 세분화  

보고서 메트릭

세부

예측 기간

2024년부터 2031년까지

기준 연도

2023

역사적 연도

2022 (2016-2021년까지 사용자 정의 가능)

양적 단위

매출은 10억 달러, 볼륨은 단위, 가격은 10억 달러

다루는 세그먼트

바이러스 유형(단순포진 및 대상포진), 제품(아시클로비르, 도코사놀, 발라시클로비르, 파미시클로비르 및 기타), 약물 유형(처방약 및 일반의약품), 연령(성인 및 소아), 투여 경로(국소, 경구 및 비경구), 유통 채널(병원 약국, 소매 약국, 약국, 온라인 약국 및 기타), 최종 사용자(병원, 전문 병원 및 기타)

적용 국가

미국, 캐나다 및 멕시코(북미), 독일, 프랑스, ​​영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양(APAC), 사우디 아라비아, UAE, 남아프리카, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 기타 중동 및 아프리카(MEA), 브라질, 아르헨티나 및 남미의 일부인 기타 남미

시장 참여자 포함

Abbott(미국), Apotex, Inc.(캐나다), Avet Pharmaceuticals, Inc.(미국), Bausch Health Companies, Inc.(캐나다), Cipla, Inc.(인도), Dr. Reddy's Laboratories Ltd.(인도), Fresenius Kabi AG(독일), GSK plc(영국), GLENMARK PHARMACEUTICALS LTD(인도), Maruho Co.,Ltd.(일본), Mylan NV(미국), Pfizer Inc.(미국), Sun Pharmaceutical Industries Ltd.(인도), Teva Pharmaceutical Industries Ltd.(이스라엘), Zydus Pharmaceuticals, Inc.(인도), Recordati Industria Chimica e Farmaceutica SpA(이탈리아), Aurobindo Pharma(인도), Amneal Pharmaceuticals LLC(미국), Slavia Pharm SRL(루마니아), Blistex, Inc.(미국)

시장 기회
  • 효능 개선을 위한 개인화된 의학 접근 방식
  • 원격진료 플랫폼, 진료 접근성 확대

시장 정의

헤르페스는 단순포진바이러스(HSV)로 인한 바이러스성 감염으로, 통증이 있는 물집이나 궤양이 반복적으로 발생하는 것이 특징입니다. HSV-1은 주로 입과 얼굴에 영향을 미치는 반면, HSV-2는 일반적으로 생식기 부위를 표적으로 삼습니다. 감염된 사람과 직접 접촉을 통해 퍼지며, 증상에는 가려움증, 따끔거림, 타는 듯한 감각이 포함될 수 있습니다.

글로벌 헤르페스 시장 역학

운전자

  • 예방 및 치료에 대한 인식 증가

공중 보건 캠페인, 교육 이니셔티브, 옹호 프로그램에 대한 노력은 헤르페스 전염, 증상 및 이용 가능한 치료법에 대한 이해를 높였습니다. 인식이 커짐에 따라 개인은 예방 조치와 치료 옵션을 찾는 경향이 더 커져 시장 확장에 기여합니다. 궁극적으로 이러한 높아진 인식은 헤르페스 시장을 앞으로 나아가게 하는 중요한 원동력이 됩니다.

  • 조기 감지를 강화하는 개선된 진단 기술

PCR 검사 및 혈청 검사와 같은 고급 검사 방법을 통해 헤르페스 감염을 더 빠르고 정확하게 식별할 수 있습니다. 조기 발견은 신속한 치료 시작을 용이하게 하여 전염률과 증상의 심각성을 줄입니다. 결과적으로 이러한 진단 도구에 대한 수요가 급증하여 헤르페스 시장 내 성장을 촉진하는 핵심 동인이 됩니다.

기회

  • 효능 개선을 위한 개인화된 의학 접근 방식

헤르페스 시장에서 개인화된 의학은 유전적, 환경적, 라이프스타일 요인에 따라 개별 환자에게 치료를 맞춤화합니다. 이 접근 방식을 통해 각 환자에게 가장 효과적인 치료법을 정확하게 식별하여 부작용을 줄이고 결과를 개선할 수 있습니다. 유전자 검사와 데이터 분석의 발전으로 개인화된 의학은 치료 전략을 최적화하고 헤르페스 감염을 더 잘 관리하여 환자의 다양한 요구를 충족하는 동시에 전반적인 효능을 향상시킬 수 있는 기회를 제공합니다.

  • 원격진료 플랫폼, 진료 접근성 확대

Telemedicine platforms offer convenient access to herpes care, enabling remote consultations, prescriptions, and follow-ups. This approach eliminates geographical barriers, especially in underserved areas, and enhances patient engagement. With the rise of virtual healthcare, individuals can seek timely treatment and advice without the need for in-person visits. In the herpes market, leveraging telemedicine platforms presents an opportunity to improve accessibility, increase patient satisfaction, and ultimately optimize disease management.

Restraints/Challenges

  • Regulatory Hurdles Delay Approval of New Treatments

The regulatory hurdles delays prolong the introduction of innovative therapies, limiting the market's ability to offer advanced solutions. Consequently, patients may face continued reliance on existing treatments, potentially hindering their efficacy and overall satisfaction. Moreover, the slower pace of introducing new products could stifle competition and innovation within the market, impacting its overall growth potential and the ability to address evolving patient needs.    

  • High Cost of Prescription Medications Hinders Access

The high cost of prescription medications limits the affordability of necessary treatments, potentially leading to financial strain or the inability to obtain medication altogether. As a result, individuals may forego or delay treatment, leading to prolonged suffering and increased transmission risks. Moreover, the financial burden on patients could discourage them from seeking proper medical care, impacting the market's overall revenue and growth potential.

This global herpes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global herpes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In October 2022, Replay, a genome writing company, introduced Eudora, a gene therapy firm focused on treating genetic retinal diseases using synHSV, a high payload capacity HSV delivery vector. This marks the debut of Replay's product companies utilizing synHSV, signaling a significant advancement in HSV-based gene therapy within the herpes market
  • In August 2022, Rational Vaccines began a clinical trial in the U.K. to evaluate baseline characteristics of patients with recurrent symptomatic HSV type 2, informing protocol design for their lead HSV-2 therapeutic vaccine candidate. This underscores Rational Vaccines' commitment to advancing herpes treatment and prevention, aiming to revolutionize disease management within the herpes market

Global Herpes Market Scope

The global herpes market is segmented on the basis of virus type, product, drug type, age, route of administration, distribution channel, and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Virus Type

  • Herpes Simplex
  • Herpes Zoster

Product

  • Acyclovir
  • Docosanol
  • Valacyclovir
  • Famciclovir
  • Others

Drug Type

  • Prescription Drug
  • Over-the-counter Drug

 Age

  • Adult
  • Pediatrics

Route of Administration

  • Topical
  • Oral
  • Parenteral

 Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

 End Users

  • Hospitals
  • Speciality Clinics
  • Others

Global Herpes Market Regional Analysis/Insights

The global herpes market is analysed and market size insights and trends are provided by virus type, product, drug type, age, route of administration, distribution channel, and end users as referenced above.

The countries covered in the global herpes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to lead the global herpes market, driven by a rising prevalence of herpes infections in the region. The U.S., in particular, dominates this market, spearheading growth due to escalating herpes cases. This underscores the region's pivotal role in shaping the trajectory of the herpes market on a global scale.

The Asia-Pacific region anticipates significant growth in the herpes market from 2024 to 2031, attributed to an increasing geriatric population in countries such as China, Japan, and India. China leads this growth, fueled by rising disposable income levels. This underscores a growing market opportunity driven by demographic shifts and economic factors in the region.

유럽은 2024년부터 2031년까지 이 지역의 기술 발전에 힘입어 헤르페스 시장이 상당히 성장할 것으로 예상합니다. 독일은 유럽 내에서 우위를 점하고 있으며, 시장 참여자들의 강력한 입지를 활용하고 있습니다. 이는 유럽에서 헤르페스 시장의 궤적을 형성하는 데 있어 기술과 경쟁 환경의 중심적 역할을 강조합니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

의료 인프라 성장 설치 기반 및 신기술 침투

글로벌 헤르페스 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 글로벌 헤르페스 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 글로벌 헤르페스 시장에 미치는 영향. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 글로벌 헤르페스 시장 점유율 분석

글로벌 헤르페스 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 헤르페스 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 헤르페스 시장에서 활동하는 주요 기업은 다음과 같습니다.

  • 애벗(미국)
  • Apotex, Inc. (캐나다)
  • Avet Pharmaceuticals, Inc. (미국)
  • Bausch Health Companies, Inc. (캐나다)
  • Cipla, Inc. (인도)
  • Dr. Reddy's Laboratories Ltd. (인도)
  • Fresenius Kabi AG(독일)
  • GSK plc (영국)
  • GLENMARK PHARMACEUTICALS LTD(인도)
  • 마루호 주식회사(일본)
  • 마일런 NV(미국)
  • 파이저 주식회사(미국)
  • Sun Pharmaceutical Industries Ltd. (인도)
  • Teva Pharmaceutical Industries Ltd. (이스라엘)
  • Zydus Pharmaceuticals, Inc. (인도)
  • Recordati Industria Chimica e Farmaceutica SpA(이탈리아)
  • Aurobindo Pharma(인도)
  • Amneal Pharmaceuticals LLC(미국)
  • Slavia Pharm SRL(루마니아)
  • 블리스텍스 주식회사(미국)

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL HERPES MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. Virus type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
    1. Summary write up (North America)
      1. OVERVIEW
    2. Summary write up (Europe)
      1. OVERVIEW
    3. Summary write up (Asia-Pacific)
      1. OVERVIEW
    4. Summary write up (South America)
      1. OVERVIEW
    5. Summary write up (Middle East and Africa)
      1. OVERVIEW
  5. global HERPES market: regulations
    1. THE U.S. REGULATORY FRAMEWORK
    2. CANADA REGULATORY FRAMEWORK
    3. THE EUROPE REGULATORY FRAMEWORK
    4. INDIA REGULATORY FRAMEWORK
  6. market overview
    1. drivers
    2. INCREASING geriatric population
      1. INCREASE IN prevalence of HERPES infections
      2. INCREASE IN NUMBER OF PRODUCT APPROVALS AND LAUNCHES
      3. RISING NUMBER OF Immunocompromised PEOPLE
    3. Restraints
      1. High cost of Anti-Herpetic medicines
      2. product recall
    4. opportunities
      1. strategic initiatives by the market players
      2. increasing healthcare expenditure
      3. SOARING NUMBER OF anti-herpetic drugs MANUFACTURERS
      4. RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
    5. challenges
      1. disruption in the supply chain of herpes drugs and injections during covid-19
      2. lack of workforce in pharma industries
  7. IMPACT OF COVID-19 ON GLOBAL HERPES MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS
    5. CONCLUSION
  8. GLOBAL HERPES MARKET, By VIRUS TYPE
    1. overview
    2. herpes simplex
      1. TYPE I
      2. TYPE II
    3. herpes zoster
  9. GLOBAL HERPES MARKET, By PRODUCT TYPE
    1. overview
    2. ACYCLOVIR
    3. Docosanol
    4. Valacyclovir
    5. Famciclovir
    6. others
  10. GLOBAL HERPES MARKET, By drug type
    1. overview
    2. Prescription Drug
    3. Over-The Counter Drug
  11. Global HERPES market, By age
    1. overview
    2. adult
    3. pediatrics
  12. Global herpes market, By ROUTE of administration
    1. overview
    2. topical
    3. oral
    4. Parenteral
  13. Global herpes market, By DISTRIBUTION CHANNEL
    1. overview
    2. hospitals pharmacies
    3. retail pharmacies
    4. Drug Stores
    5. Online Pharmacies
    6. others
  14. global herpes market, By end users
    1. overview
    2. hospitals
    3. Speciality Clinics
    4. Others
  15. GLOBAL herpes MARKET, BY REGION
    1. overview
    2. North AMERICA
      1. U.S.
      2. Canada
      3. Mexico
    3. europe
      1. Germany
      2. france
      3. U.K.
      4. Italy
      5. Spain
      6. russia
      7. turkey
      8. belgium
      9. netherlands
      10. switzerland
      11. luxemburg
      12. rest of europe
    4. Asia-pacific
      1. China
      2. India
      3. japan
      4. south korea
      5. australia
      6. Singapore
      7. thailand
      8. malaysia
      9. indonesia
      10. philippines
      11. rest of asia-pacific
    5. SOUTH AMERICA
      1. BRAZIL
      2. ARGENTINA
      3. REST OF SOUTH AMERICA
    6. middle east and africa
      1. south africa
      2. saudi arabia
      3. U.A.E.
      4. egypt
      5. israel
      6. rest of middle east and africa
  16. Global Herpes Market: COMPANY landscape
    1. company share analysis: Global
    2. company share analysis: North America
    3. company share analysis: Europe
    4. company share analysis: Asia-Pacific
  17. swot analysis
  18. company profile
    1. GLAXOSMITHKILNE PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    3. Fresenius Kabi AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    6. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. Amneal Pharmaceuticals LLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. apotex inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    10. Avet Pharmaceuticals Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. Bausch Health Companies Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. blistex, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. cipla, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. Dr. Reddy’s Laboratories Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    15. EPIHEALTH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. Glenmark Pharmaceutical Inc., USA (A Subsidiary of Glenmark Pharmaceuticals Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    17. Maruho Co.,Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. RECORDATI S.p.A.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. Slavia Pharm S.R.L.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    20. Sun Pharmaceutical Industries Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    21. Zydus Pharmaceuticals, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  19. questionnaire
  20. related reports

표 목록

TABLE 1 The EMA has seven scientific committees that carry out its scientific assessments:

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 3 MANUFACTURERS OF ANTI-HERPETIC DRUGS

TABLE 4 GLOBAL HERPES MARKET, By VIRUS Type, 2019-2028 (USD million)

TABLE 5 Global Herpes Simplex in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 6 Global Herpes Simplex in Herpes Market, By Virus Type, 2019-2028 (USD Million)

TABLE 7 Global Herpes Zoster in Herpes Market, BY Region, 2019-2028 (USD Million)

TABLE 8 Global Herpes Market, By Product Type, 2019-2028 (USD Million)

TABLE 9 Global Acyclovir in Herpes Market, BY Region, 2019-2028 (USD Million)

TABLE 10 Global Docosanol in Herpes Market, By Region, 2019-2028 (USD Million)

TABLE 11 Global Valacyclovir in Herpes Market, By region, 2019-2028 (USD Million)

TABLE 12 Global Famciclovir in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 13 Global Others in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 14 Global Herpes Market, By Drug Type, 2019-2028 (USD Million)

TABLE 15 Global prescription drug in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 16 Global Over-The Counter Drug in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 17 Global Herpes Market, By Age, 2019-2028 (USD Million)

TABLE 18 Global Adult in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 19 Global Pediatrics in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 20 Global Herpes Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 21 Global Topical in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 22 Global Oral in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 23 Global Parenteral in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 24 Global Herpes Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 25 Global Hospitals Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 26 Global Retail Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 27 Global Drug Stores in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 28 Global Online Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 29 Global Others in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 30 Global Herpes Market, By End Users, 2019-2028 (USD Million)

TABLE 31 Global Hospitals in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 32 Global Speciality Clinics in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 33 Global Others in Herpes Market, by region, 2019-2028 (USD Million)

TABLE 34 GLOBAL herpes market, By region, 2019-2028 (usd THOUSAND)

TABLE 35 NORTH AMERICA HERPES market, By Country, 2019-2028 (USD Million)

TABLE 36 NORTH AMERICA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 37 NORTH AMERICA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 38 NORTH AMERICA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 39 NORTH AMERICA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 40 NORTH AMERICA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 41 NORTH AMERICA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 42 NORTH AMERICA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 43 NORTH AMERICA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 44 U.S. HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 45 U.S. herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 46 U.S. HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 47 U.S. HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 48 U.S. HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 49 U.S. HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 50 U.S. HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 51 U.S. HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 52 CANADA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 53 CANADA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 54 canada HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 55 CANADA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 56 CANADA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 57 CANADA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 58 CANADA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 59 CANADA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 60 MEXICO HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 61 MEXICO herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 62 MEXICO HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 63 MEXICO HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 64 MEXICO HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 65 MEXICO HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 66 MEXICO HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 67 MEXICO HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 68 EUROPE HERPES market, By Country, 2019-2028 (USD Million)

TABLE 69 EUROPE HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 70 EUROPE herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 71 EUROPE HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 72 EUROPE HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 73 EUROPE HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 74 EUROPE HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 75 EUROPE HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 76 EUROPE HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 77 GERMANY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 78 GERMANY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 79 GERMANY HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 80 GERMANY HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 81 GERMANY HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 82 GERMANY HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 83 GERMANY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 84 GERMANY HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 85 france HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 86 france herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 87 FRANCE HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 88 FRANCE HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 89 FRANCE HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 90 FRANCE HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 91 FRANCE HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 92 FRANCE HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 93 U.K. HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 94 U.K. herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 95 U.K. HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 96 U.K. HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 97 U.K. HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 98 U.K. HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 99 U.K. HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 100 U.K. HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 101 ITALY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 102 ITALY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 103 ITALY HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 104 ITALY HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 105 ITALY HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 106 ITALY HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 107 ITALY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 108 ITALY HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 109 SPAIN HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 110 SPAIN herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 111 SPAIN HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 112 SPAIN HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 113 SPAIN HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 114 SPAIN HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 115 SPAIN HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 116 SPAIN HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 117 RUSSIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 118 RUSSIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 119 RUSSIA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 120 RUSSIA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 121 RUSSIA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 122 RUSSIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 123 RUSSIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 124 RUSSIA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 125 TURKEY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 126 TURKEY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 127 TURKEY HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 128 TURKEY HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 129 TURKEY HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 130 TURKEY HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 131 TURKEY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 132 TURKEY HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 133 BELGIUM HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 134 BELGIUM herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 135 BELGIUM HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 136 BELGIUM HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 137 BELGIUM HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 138 BELGIUM HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 139 BELGIUM HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 140 BELGIUM HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 141 netherlands HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 142 NETHERLANDS herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 143 NETHERLANDS HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 144 NETHERLANDS HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 145 NETHERLANDS HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 146 NETHERLANDS HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 147 NETHERLANDS HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 148 NETHERLANDS HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 149 SWITZERLAND HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 150 SWITZERLAND herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 151 SWITZERLAND HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 152 SWITZERLAND HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 153 SWITZERLAND HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 154 SWITZERLAND HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 155 SWITZERLAND HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 156 SWITZERLAND HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 157 LUXEMBURG HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 158 LUXEMBURG herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 159 LUXEMBURG HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 160 LUXEMBURG HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 161 LUXEMBURG HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 162 LUXEMBURG HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 163 LUXEMBURG HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 164 LUXEMBURG HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 165 rest of europe HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 166 ASIA-PACIFIC HERPES market, By Country, 2019-2028 (USD Million)

TABLE 167 ASIA-PACIFIC HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 168 ASIA-PACIFIC herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 169 ASIA-PACIFIC HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 170 ASIA-PACIFIC HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 171 ASIA-PACIFIC HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 172 ASIA-PACIFIC HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 173 ASIA-PACIFIC HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 174 ASIA-PACIFIC HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 175 CHINA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 176 CHINA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 177 CHINA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 178 CHINA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 179 CHINA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 180 CHINA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 181 CHINA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 182 CHINA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 183 india HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 184 india herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 185 india HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 186 india HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 187 INDIA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 188 INDIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 189 INDIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 190 INDIA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 191 JAPAN HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 192 JAPAN herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 193 JAPAN HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 194 JAPAN HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 195 JAPAN HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 196 JAPAN HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 197 JAPAN HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 198 JAPAN HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 199 SOUTH KOREA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 200 SOUTH KOREA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 201 SOUTH KOREA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 202 SOUTH KOREA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 203 SOUTH KOREA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 204 SOUTH KOREA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 205 SOUTH KOREA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 206 SOUTH KOREA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 207 AUSTRALIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 208 AUSTRALIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 209 AUSTRALIA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 210 AUSTRALIA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 211 AUSTRALIA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 212 AUSTRALIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 213 AUSTRALIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 214 AUSTRALIA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 215 SINGAPORE HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 216 SINGAPORE herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 217 SINGAPORE HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 218 SINGAPORE HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 219 SINGAPORE HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 220 SINGAPORE HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 221 SINGAPORE HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 222 SINGAPORE HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 223 THAILAND HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 224 THAILAND herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 225 THAILAND HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 226 THAILAND HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 227 THAILAND HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 228 THAILAND HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 229 THAILAND HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 230 THAILAND HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 231 malaysia HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 232 MALAYSIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 233 MALAYSIA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 234 MALAYSIA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 235 MALAYSIA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 236 MALAYSIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 237 MALAYSIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 238 MALAYSIA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 239 INDONESIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 240 INDONESIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 241 INDONESIA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 242 INDONESIA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 243 INDONESIA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 244 INDONESIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 245 INDONESIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 246 INDONESIA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 247 PHILIPPINEs HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 248 PHILIPPINEs herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 249 PHILIPPINEs HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 250 PHILIPPINES HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 251 PHILIPPINES HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 252 PHILIPPINES HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 253 PHILIPPINES HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 254 PHILIPPINES HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 255 rest of ASIA-pacific HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 256 SOUTH AMERICA HERPES market, By Country, 2019-2028 (USD Million)

TABLE 257 SOUTH AMERICA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 258 SOUTH AMERICA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 259 SOUTH AMERICA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 260 SOUTH AMERICA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 261 SOUTH AMERICA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 262 SOUTH AMERICA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 263 SOUTH AMERICA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 264 SOUTH AMERICA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 265 BRAZIL HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 266 BRAZIL herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 267 BRAZIL HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 268 BRAZIL HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 269 BRAZIL HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 270 BRAZIL HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 271 BRAZIL HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 272 BRAZIL HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 273 ARGENTINA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 274 ARGENTINA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 275 ARGENTINA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 276 ARGENTINA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 277 ARGENTINA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 278 ARGENTINA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 279 ARGENTINA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 280 ARGENTINA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 281 Rest of south america HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 282 MIDDLE EAST AND AFRICA HERPES market, By Country, 2019-2028 (USD Million)

TABLE 283 MIDDLE EAST AND AFRICA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 284 MIDDLE EAST AND AFRICA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 285 MIDDLE EAST AND AFRICA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 286 MIDDLE EAST AND AFRICA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 287 MIDDLE EAST AND AFRICA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 288 MIDDLE EAST AND AFRICA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 289 MIDDLE EAST AND AFRICA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 290 MIDDLE EAST AND AFRICA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 291 SOUTH AFRICA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 292 SOUTH AFRICA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 293 SOUTH AFRICA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 294 SOUTH AFRICA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 295 SOUTH AFRICA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 296 SOUTH AFRICA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 297 SOUTH AFRICA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 298 SOUTH AFRICA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 299 SAUDI ARABIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 300 SAUDI ARABIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 301 SAUDI ARABIA HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 302 SAUDI ARABIA HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 303 SAUDI ARABIA HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 304 SAUDI ARABIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 305 SAUDI ARABIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 306 SAUDI ARABIA HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 307 U.A.E. HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 308 U.A.E. herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 309 U.A.E. HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 310 U.A.E. HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 311 U.A.E. HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 312 U.A.E. HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 313 U.A.E. HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 314 U.A.E. HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 315 EGYPT HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 316 EGYPT herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 317 EGYPT HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 318 EGYPT HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 319 EGYPT HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 320 EGYPT HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 321 EGYPT HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 322 EGYPT HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 323 ISRAEL HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

TABLE 324 ISRAEL herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)

TABLE 325 ISRAEL HERPES MARKET, By product type, 2019-2028 (USD Million)

TABLE 326 ISRAEL HERPES MARKET, By drug type, 2019-2028 (USD Million)

TABLE 327 ISRAEL HERPES MARKET, By Age, 2019-2028 (USD Million)

TABLE 328 ISRAEL HERPES MARKET, By route of administration, 2019-2028 (USD Million)

TABLE 329 ISRAEL HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 330 ISRAEL HERPES MARKET, By End Users, 2019-2028 (USD Million)

TABLE 331 rest of middle east and africa HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)

그림 목록

FIGURE 1 GLOBAL HERPES MARKET: segmentation

FIGURE 2 GLOBAL HERPES MARKET: data triangulation

FIGURE 3 GLOBAL HERPES MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL HERPES MARKET: global vs REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL HERPES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL HERPES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL HERPES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL HERPES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 GLOBAL HERPES MARKET: vendor share analysis

FIGURE 10 GLOBAL HERPES MARKET: SEGMENTATION

FIGURE 11 increasE IN prevalence of herpes infections and rise in healthcare expenditure are expected to drive THE GLOBAL HERPES MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 herpes simplex segment is expected to account for the largest share of the GLOBAL HERPES MARKET in 2021 & 2028

FIGURE 13 North America is expected to DOMINATE the GLOBAL HERPES MARKET, and ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 asia-pacific is the fastest-growing market for herpes market manufacturers in the forecast period of 2021 to 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF global Herpes market

FIGURE 16 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)

FIGURE 17 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)

FIGURE 18 GLOBAL HERPES MARKET : By VIRUS TYPE, 2020

FIGURE 19 GLOBAL HERPES MARKET : By VIRUS TYPE, 2019-2028 (USD million)

FIGURE 20 GLOBAL HERPES MARKET : By VIRUS TYPE, CAGR (2021-2028)

FIGURE 21 GLOBAL HERPES MARKET : By VIRUS TYPE, LIFELINE CURVE

FIGURE 22 GLOBAL HERPES MARKET : By PRODUCT TYPE, 2020

FIGURE 23 GLOBAL HERPES MARKET : By PRODUCT TYPE, 2019-2028 (USD million)

FIGURE 24 GLOBAL HERPES MARKET : By PRODUCT TYPE, CAGR (2021-2028)

FIGURE 25 GLOBAL HERPES MARKET : By PRODUCT TYPE, LIFELINE CURVE

FIGURE 26 GLOBAL HERPES MARKET : By DRUG TYPE, 2020

FIGURE 27 GLOBAL HERPES MARKET : By DRUG TYPE, 2019-2028 (USD million)

FIGURE 28 GLOBAL HERPES MARKET : By DRUG TYPE, CAGR (2021-2028)

FIGURE 29 GLOBAL HERPES MARKET : By DRUG TYPE, LIFELINE CURVE

FIGURE 30 GLOBAL HERPES MARKET: By AGE, 2020

FIGURE 31 GLOBAL HERPES MARKET: By AGE, 2019-2028 (USD million)

FIGURE 32 GLOBAL HERPES MARKET: By AGE, CAGR (2021-2028)

FIGURE 33 GLOBAL HERPES MARKET: By AGE, LIFELINE CURVE

FIGURE 34 Global herpes market: By route OF administration, 2020

FIGURE 35 Global HERPES market: By route OF ADMINISTRATION, 2019-2028 (USD million)

FIGURE 36 Global HERPES market: By route OF ADMINISTRATION, CAGR (2021-2028)

FIGURE 37 Global HERPES market: By route OF ADMINISTRATION, LIFELINE CURVE

FIGURE 38 Global herpes market: distribution channel, 2020

FIGURE 39 Global herpes market: DISTRIBUTION CHANNEL, 2019-2028 (USD million)

FIGURE 40 Global herpes market: DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 41 global herpes Global market: DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 42 Global herpes market: By end users, 2020

FIGURE 43 Global herpes market: Byend users, 2019-2028 (USD million)

FIGURE 44 Global herpes market: By end users, CAGR (2021-2028)

FIGURE 45 Global herpes market: By end users, LIFELINE CURVE

FIGURE 46 GLOBAL herpes market: SNAPSHOT (2020)

FIGURE 47 GLOBAL herpes market: by region (2020)

FIGURE 48 GLOBAL herpes market: by region (2021 & 2028)

FIGURE 49 GLOBAL herpes market: by region (2020 & 2028)

FIGURE 50 GLOBAL herpes market: by VIRUS TYPE (2021-2028)

FIGURE 51 NORTH AMERICA HERPES MARKET: SNAPSHOT (2020)

FIGURE 52 NORTH AMERICA HERPES MARKET: BY COUNTRY (2020)

FIGURE 53 NORTH AMERICA HERPES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 54 NORTH AMERICA HERPES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 55 NORTH AMERICA HERPES MARKET: BY virus TYPE (2021-2028)

FIGURE 56 EUROPE HERPES MARKET: SNAPSHOT (2020)

FIGURE 57 EUROPE HERPES MARKET: BY COUNTRY (2020)

FIGURE 58 EUROPE HERPES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 59 EUROPE HERPES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 60 EUROPE HERPES MARKET: BY virus TYPE (2021-2028)

FIGURE 61 ASIA-PACIFIC HERPES MARKET: SNAPSHOT (2020)

FIGURE 62 ASIA-PACIFIC HERPES MARKET: BY COUNTRY (2020)

FIGURE 63 ASIA-PACIFIC HERPES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 64 ASIA-PACIFIC HERPES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 65 ASIA-PACIFIC HERPES MARKET: BY virus TYPE (2021-2028)

FIGURE 66 SOUTH AMERICA HERPES market: SNAPSHOT (2020)

FIGURE 67 SOUTH AMERICA HERPES market: BY COUNTRY (2020)

FIGURE 68 SOUTH AMERICA HERPES market: BY COUNTRY (2021 & 2028)

FIGURE 69 SOUTH AMERICA HERPES market: BY COUNTRY (2020 & 2028)

FIGURE 70 SOUTH AMERICA HERPES market: BY virus TYPE (2021-2028)

FIGURE 71 MIDDLE EAST AND AFRICA HERPES MARKET: SNAPSHOT (2020)

FIGURE 72 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2020)

FIGURE 73 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 74 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 75 MIDDLE EAST AND AFRICA HERPES MARKEt: BY virus TYPE (2021-2028)

FIGURE 76 GLOBAL HERPES MARKET: COMPANY SHARE 2020 (%)

FIGURE 77 North America Herpes Market: company share 2020 (%)

FIGURE 78 Europe Herpes Market: company share 2020 (%)

FIGURE 79 Asia-Pacific Herpes Market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The herpes market size will be worth USD 2.06 billion by 2031.
The growth rate of the herpes market is 6.6% in the forecast period by 2031.
Increasing awareness about prevention and treatment & improved diagnostic technologies enhancing early detection are the growth drivers of the herpes market.
Virus type, product, drug type, age, route of administration, distribution channel, and end users are the factors on which the herpes market research is based.
Major companies in the herpes market are Abbott (U.S.), Apotex, Inc. (Canada), Avet Pharmaceuticals, Inc. (U.S.), Bausch Health Companies, Inc. (Canada), Cipla, Inc. (India), Dr. Reddy’s Laboratories Ltd. (India), Fresenius Kabi AG (Germany), GSK plc (U.K.), GLENMARK PHARMACEUTICALS LTD (India), Maruho Co.,Ltd. (Japan), Mylan N.V. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Zydus Pharmaceuticals, Inc. (India), Recordati Industria Chimica e Farmaceutica S.p.A. (Italy), Aurobindo Pharma (India), Amneal Pharmaceuticals LLC (U.S.), Slavia Pharm S.R.L. (Romania), Blistex, Inc. (U.S.).

관련 페이지 탐색

Banner